# Danny H. Sugimoto, M.D., Chicago, IL – FDA Inspections

Source: https://www.keypedia.com/companies/danny-h-sugimoto-md/dc781d15-5f74-42bd-b6cc-13f572ac50b9

> Inspection records and compliance data for Danny H. Sugimoto, M.D. in Chicago, Illinois. 5 FDA inspections on record, last inspected May 23, 2019.

---

## Details

- Name: Danny H. Sugimoto, M.D.
- FEI Number: 3007207764
- Address Line 1: Cedar-Crosse Research Center, 800 S Wells St Ste M15
- City: Chicago
- State: Illinois
- Zip Code: 60607
- Country Name: United States
- Address: Cedar-Crosse Research Center, 800 S Wells St Ste M15, Chicago, Illinois 60607, United States
- Country: United States

## Related Documents

- FDA Inspection 1092841 - Danny H. Sugimoto, M.D. - 2019-05-23 — classification: No Action Indicated (NAI), source: FDA, date: May 23, 2019
- [FDA Inspection 923844 - Danny H. Sugimoto, M.D. - 2015-05-20](https://www.keypedia.com/records/fda_inspections/danny-h-sugimoto-md/77ed0254-94df-4a88-8f6b-fdc4d7db7294) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 20, 2015
- FDA Inspection 926019 - Danny H. Sugimoto, M.D. - 2015-05-20 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 20, 2015
- [FDA Inspection 860826 - Danny H. Sugimoto, M.D. - 2014-01-02](https://www.keypedia.com/records/fda_inspections/danny-h-sugimoto-md/14769f74-884e-4b80-8f27-f0a21f01c6c2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 2, 2014
- [FDA Inspection 571974 - Danny H. Sugimoto, M.D. - 2009-02-23](https://www.keypedia.com/records/fda_inspections/danny-h-sugimoto-md/e9f2e9f3-3a65-4f15-8e4c-080e2947ae86) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 23, 2009

## Related Companies

- [John G. Sonnenberg, Ph.D.](https://www.keypedia.com/companies/john-g-sonnenberg-phd/92a1e36f-f452-4ca8-ad9b-15edf097194c)
- [Horizon Therapeutics USA, Inc.](https://www.keypedia.com/companies/horizon-therapeutics-usa-inc/59538819-cd75-4621-b630-681f24563923)
- [Melissa Gilliam](https://www.keypedia.com/companies/melissa-gilliam/653d2ba6-0964-440c-800e-972d5b906d4a)
- [Dovilan L. Wyatt, M.D.](https://www.keypedia.com/companies/dovilan-l-wyatt-md/f71f1b9d-3969-4395-b626-fb2bbf5c59b8)
- [Aerocare USA](https://www.keypedia.com/companies/aerocare-usa/a07e6693-b478-4155-83dc-da818966ba9b)
- [Calumet Refining LLC](https://www.keypedia.com/companies/calumet-refining-llc/0a5dd0ae-3521-4ea3-a4d9-100e016f5bfc)
- [Jennifer A. Tuazon](https://www.keypedia.com/companies/jennifer-a-tuazon/760cfc30-29dd-43b3-8732-6ac8a7d6a357)
- [University Dermatology and Vein Clinic, LLC](https://www.keypedia.com/companies/university-dermatology-and-vein-clinic-llc/cd971fa8-4cbf-4936-b560-077836c24607)
- [PharmPro, Division of Fluid Air](https://www.keypedia.com/companies/pharmpro-division-of-fluid-air/69cd5738-81ca-4976-95d0-ac2000ce1366)
- [Adil Javed, MD, Clinical Investigator](https://www.keypedia.com/companies/adil-javed-md-clinical-investigator/29756d0b-0fda-4424-bb6d-e1bd69982b5d)
